Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.

U. Tjernlund

Abstract:

What problem does this paper attempt to address?

Comparing the Efficacy and Safety of High-Voltage and Standard-Voltage Pulsed Radiofrequency for the Treatment of Postherpetic Neuralgia: a Pooled Analysis from Randomized Controlled Trials

Shihong Cai,Li Du,Qiaoming Xiang,Chengjiang Liu,Yanfeng Zhang,Zhiyou Peng,Xianhui Kang,Zhiying Feng

DOI: https://doi.org/10.1016/j.heliyon.2024.e30525

IF: 3.776

2024-01-01

Heliyon

Abstract:Postherpetic neuralgia (PHN) is one of the most common and serious complications of herpes zoster infection. Pulsed radiofrequency (PRF) therapy has emerged to be a neuromodulation technique for the treatment of PHN. Two therapeutic options are available for PRF, including high-voltage and standard-voltage PRF. Some studies suggested that the former one had better clinical efficacy than the latter one. For the first time, this pooled analysis compared the efficacy and safety of these two surgeries for the treatment of PHN. Five commonly used databases were applied to identify the eligible studies. This study was registered on the PROSPERO (ID: CRD42023460236), which provided more relevant information. Finally, four randomized controlled trials (RCTs) with 285 participants were included. The combined odds ratios (OR) showed that high-voltage PRF exhibited a significantly higher treatment efficiency than the standard PRF (OR = 1.4, 95%CI: 1.16 to 1.69, P<0.001). Additionally, the visual analogue scale (VAS) in the high-voltage PRF group was significantly lower than that of the standard PRF group at one week (SMD = -0.776, 95%CI: -1.408 to -0.145, P =0.016), one month (SMD = -0.544, 95%CI: -0.907 to -0.180, P =0.003), and three months (SMD = -1.096, 95%CI: -1.504 to -0.687, P <0.001) after treatment, particularly at the three months after surgery. However, the VAS was comparable between the two groups (SMD = -0.94, 95%CI: -1.985 to 0.104, P =0.077). Patients who underwent high-voltage PRF did not have a significantly higher incidence of adverse events than those with standard PRF (OR = 1.56, 95%CI: 0.78 to 3.13, P=0.208). In summary, the current study revealed that high-voltage PRF is superior to standard-voltage PRF in improving analgesic efficacy in patients with PHN. Additionally, it does not increase the incidence of treatment-related adverse effects. Further studies are still warranted to determine the optimal voltage and duration of PRF treatment for patients with PHN.
Effect of CT-Guided Repeated Pulsed Radiofrequency on Controlling Acute/Subacute Zoster-Associated Pain: A Retrospective Cohort Study

Min Rui,Zixin Han,Longsheng Xu,Ming Yao

DOI: https://doi.org/10.1007/s40122-023-00567-1

Abstract:Introduction: Zoster-associated pain (ZAP) treatment and management is still inadequate. Repeated intervention protocol is often applied to manage ZAP. This study aimed to retrospectively investigate the effect of repeated applications of pulsed radiofrequency therapy on controlling acute/subacute ZAP. Methods: From March 2019 to December 2021, 150 patients with acute/subacute ZAP who underwent repeated application of pulsed radiofrequency treatment (R-PRF) and pulsed radiofrequency combined paravertebral block interventions (PRF + PVB) in the Pain Department of the affiliated Hospital of Jiaxing University were enrolled. Patients were grouped by intervention protocol and received at least 12 months of follow-up assessments using the Numerical Rating Scale score (NRSs), Pittsburg Sleep Quality Index (PSQI), Simple McGill Pain Questionnaire-2 score (SF-MPQ-2s), and follow-up interventions. Results: Both groups experienced a reduction in the incidence of clinically meaningful ZAP after the intervention therapy. In the R-PRF group, there were 36 cases of clinically meaningful ZAP within the first month post-treatment, while the PRF + PVB group had 38 cases. The incidence of clinically meaningful ZAP, as determined by multivariable generalized estimating equations, was 42.86% in the R-PRF group and 57.58% in the PRF + PVB group during the first month of follow-up. There was a significant difference in the incidence of clinically meaningful ZAP between the two groups after 1 month of treatment (adjusted odds ratio: 0.40; 95% confidence interval: 0.18-0.91; p = 0.03). Conclusions: Both R-PRF and PRF + PVB treatments effectively relieve pain in patients with acute/subacute ZAP. However, R-PRF may have superior efficacy compared to PRF + PVB in reducing the incidence of clinically meaningful ZAP 1 month after treatment.
Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated Pain

Zhiyou Peng,Jianguo Guo,Yanfeng Zhang,Xuejiao Guo,Wenguang Huang,Yunze Li,Zhe Yan,Nannan Guo,Daqiang Ke,Li Chen,Jinyan Huang,Zhiying Feng

DOI: https://doi.org/10.1007/s40122-022-00355-3

IF: 3.96

2022-01-30

Pain and Therapy

Abstract:IntroductionZoster-associated pain (ZAP), which may cause anxiety, depression, and sleep disorders and reduce quality of life, is often refractory to current standard treatments. Studies have shown that pulsed radiofrequency (PRF) can alleviate ZAP and reduce the incidence of postherpetic neuralgia (PHN). This study aimed to explore the clinical characteristics associated with PRF responsiveness, develop a model for identifying risk factors of inadequate PRF management, and help clinicians make better decisions.MethodsPatients who underwent PRF for ZAP between January 2017 and October 2020 in our hospital were included in this study. Patients were evaluated using the numerical rating scale (NRS), Insomnia Severity Index, Patient Health Questionnaire-9, and 36-Item Short Form Health Survey (SF-36) before and 3 months after the procedure. Patient demographic data and blood test results were also collected. We defined the effectiveness of PRF for ZAP as relief of > 50% in NRS scores compared to pre-PRF. Least absolute shrinkage and selection operator (LASSO) regression analyses were subsequently performed to identify factors related to the therapeutic effect of PRF in patients with ZAP. The performance of the prediction model was assessed by the area under the receiver operating characteristic curve (AUC).ResultsThe effectiveness of PRF in patients with ZAP was 69.6% (total 313 patients) after 3 months. LASSO regression analysis extracted the seven most powerful features in the developed prediction model: sex, stage of herpes zoster (HZ), pregabalin dose, bodily pain indicators of SF-36, lymphocyte count, and low-density lipoprotein cholesterol (LDLC) and complement C4 in peripheral blood. Model = 1.586 + 0.148 × lymphocyte + (−0.001) × bodily pain indicators of SF-36 + (−0.001) × pregabalin dose + 0.028 × LDLC + 0.001 × C4 + (−0.508) × sex + (−0.128) × stage of HZ. We generated the ROC curve for the prediction model, and the final AUC was 0.701. The sensitivity, specificity, and overall accuracy of the model were 90%, 33%, and 73%, respectively.ConclusionsSeven factors were significantly associated with poor PRF outcome: male sex, advanced stage of HZ, higher pregabalin dose, higher bodily pain indicators of SF-36, and lower lymphocyte count, LDLC, and complement C4 in the peripheral blood. PRF should be applied to patients with ZAP as early as possible to achieve satisfactory outcomes.

clinical neurology
Clinical efficacy of high-voltage pulsed radiofrequency combined with stellate ganglion block in the acute phase of thoracic and dorsal herpes zoster neuralgia under dual guidance of ultrasound and C-arm

Yong Sun,Xiaoxue Zhao,Fucheng Dai,Wei Zhang,Wu Liu,Fei Yu

DOI: https://doi.org/10.1016/j.jocn.2024.06.023

Abstract:Objectives: A single therapeutic approach is not always successful in the treatment of herpes zoster neuralgia, and the appropriate combination of different treatments deserves further exploration. In this study, we investigated the clinical efficacy of high-voltage long-duration pulsed radiofrequency (PRF) combined with stellate ganglion block (SGB) in the acute phase of thoracic and dorsal herpes zoster neuralgia under dual guidance of ultrasound and C-arm. Methods: 79 cases of acute zoster neuralgia were grouped premised upon differing therapeutic approaches: standard voltage PRF (group S, the temperature, duration, pulse width, frequency and voltage were set to 42 °C, 300 s, 20 ms, 2 Hz, and 45 V), high-voltage long-duration PRF (group H, parameters of PRF were set to 42 °C, 900 s, 20 ms, 2 Hz, and 90 V, respectively), and high-voltage long-duration PRF combined with SGB (group C, parameter settings for PRF are the same as those for group H). The therapeutic outcomes were assessed utilizing the numeric rating scale (NRS), Pittsburgh sleep quality index (PSQI), and Hamilton anxiety rating scale (HAMA). The incidence of clinically significant postherpetic neuralgia post-treatment had been documented. Results: Compared to baseline, scores of NRS, PSQI, and HAMA at each time point post-treatment decreased across all groups, and the decrease was more significant in the C group than in the S group. At the later stage of treatment, the consumption of pregabalin and tramadol and the plasma levels of interleukin-6 and galectin-3 in the C group were significantly lower than those in the S group. The incidence of PHN in the C group was significantly lower than in the S group. Conclusions: The combination of high-voltage long-duration PRF combined with SGB under dual guidance of ultrasound and C-arm represents a safe, effective, environmentally friendly, and cost-efficient method for treating AZN, significantly improving sleep quality, alleviating anxiety, and reducing the risk of PHN occurrence.
Effective treatment of high-voltage pulsed radiofrequency combined with oxygen-ozone injection in acute zoster neuralgia

Li-Mei Li,Zhi-Li Zhang,Bao-Sen Zheng,Li-Li Jia,Wen-Li Yu,Hong-Yin Du

DOI: https://doi.org/10.1016/j.clineuro.2022.107496

Abstract:Introduction: Postherpetic neuralgia (PHN) is the most common and severe complication of acute herpes zoster. Early treatment of herpes zoster neuralgia is of great significance to reduce the incidence of PHN. This retrospective study evaluated the efficacy and safety of the combination of high-voltage pulsed radiofrequency (PRF) and oxygen-ozone(O2-O3) injection in patients with acute zoster neuralgia (AZN) who failed to respond to conservative treatment. Methods: One-hundred patients diagnosed with AZN were classified into two groups (high-voltage PRF group [HP group, n = 50] and high-voltage PRF combined with O2-O3 injection group [HPO group, n = 50]) based on different treatment methods. Therapeutic effectiveness was assessed using a numerical rating scale (NRS) and the Pittsburgh Sleep Quality Index (PSQI). The dosages of gabapentin and tramadol (mg/d) before treatment and after 1 week and 1, 3, and 6 months of treatment were measured. The incidence of clinically meaningful PHN after treatment was also recorded. Results: Pain intensity and sleep quality in both groups at all time points improved after treatment compared to before treatment (P < 0.05). After 1 week and 1 month of treatment, NRS and PSQI scores in both groups decreased, but the differences were not statistically significant (P > 0.05). NRS, PSQI scores, and the dosages of gabapentin and tramadol decreased more significantly in the HPO group than those in the HP group after 3 months (P < 0.05). The incidence of PHN was significantly lower in the HPO group than in the HP group (P < 0.05). There were no significant differences in adverse events between the groups. Conclusions: High-voltage PRF is a safe and effective method for treating AZN. The combination of high-voltage PRF and O2-O3 injection is superior to high-voltage PRF alone for treating late-stage AZN. This approach could be recommended as an alternative treatment for patients with refractory AZN and could significantly reduce the risk of PHN.
Gonadotropin-releasing hormone and prostaglandin F2 alpha for postpartum dairy cows: estrous, ovulation, and fertility traits.

M. Benmrad,J. Stevenson

DOI: https://doi.org/10.3168/JDS.S0022-0302(86)80469-6

IF: 4.225

1986-03-01

Journal of Dairy Science

Abstract:A study of 234 Holstein cows was conducted to determine if early postpartum treatments of gonadotropin-releasing hormone, prostaglandin F2 alpha, or both would alter frequency and occurrence of estrus and ovulation as well as subsequent fertility. Cows in groups 1 and 2 received gonadotropin-releasing hormone (200 micrograms) between 10 and 14 d postpartum, and cows in groups 3 and 4 received saline. Ten days later, cows in groups 2 and 3 received prostaglandin F2 alpha (25 mg), and cows in groups 1 and 4 received saline. Treatment with gonadotropin-releasing hormone reduced intervals to first ovulation and first detected estrus as well as increasing the proportion of cows with three or more ovulations before first service from 57% for saline-treated controls to 83%. Treatment with prostaglandin F2 alpha reduced intervals to second and third ovulation and shortened the first estrous cycle. Treatments for cows in groups 1 and 3 increased the proportion of cows having estrous cycles of normal duration. Interval from calving to conception was reduced by 43 to 48 d for cows with an abnormal puerperium treated with either gonadotropin-releasing hormone or prostaglandin F2 alpha compared with controls (group 4) and by 27 to 29 d overall in all cows in groups 1 and 3. Cows with normal or abnormal puerperium in groups 1 and 3 required 26 to 41% fewer services per conception than controls. We conclude that treatments of gonadotropin releasing hormone or prostaglandin F2 alpha, but not the treatment combination, improved fertility of dairy cows, especially those that experienced puerperal problems.
A central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain

Xuelian Li,Huaxiang Zhang,Xu Zhang,Ke Ma,Yan Lv,Tao Song,Gangwen Guo,Dong Huang

DOI: https://doi.org/10.1038/s41598-024-75890-4

2024-10-21

Abstract:Spinal cord stimulation (SCS) has shown effectiveness in relieving zoster-associated pain (ZAP), but some patients still experience moderate or severe pain after SCS treatment. This study aims to evaluate the impact of SCS combined with dorsal root ganglion (DRG) pulsed radiofrequency (PRF) as a dual neuromodulation strategy on the prognosis of ZAP. The clinical records of patients diagnosed with ZAP who underwent SCS (SCS group) or SCS combined with PRF (SCS + PRF group) at The Third Xiangya Hospital, Central South University, were retrospectively analyzed to compare the effectiveness of the two treatment approaches for ZAP. Outcome measures included changes in Visual Analog Scale (VAS) scores before and after neuromodulation treatment, response rates, and incidence of progression to postherpetic neuralgia (PHN).13 SCS patients and 15 SCS + PRF patients were analyzed. Admission VAS scores were similar (P = 0.934). Upon discharge, no significant differences in VAS or response rates were observed (P > 0.05). However, at 6-month follow-up, the SCS + PRF group had lower VAS scores (1.53 ± 1.06 vs. 3.23 ± 1.50, P < 0.001) and a lower proportion of residual moderate pain (P = 0.041). None in the SCS + PRF group progressed to PHN in the acute/subacute phases, differing significantly from the SCS group (P = 0.038).Therefore, SCS combined with DRG PRF is feasible and effective in the treatment of ZAP. This dual neuromodulation strategy may be a more appropriate regimen for the treatment of ZAP.
Effect of Repeated High-voltage Long-duration Pulsed Radiofrequency on Herpetic Neuralgia

Enming Zhang,Yong Fei,Longsheng Xu,Bing Huang,Ming Yao

IF: 4.396

Pain Physician

Abstract:Background: Pulsed radiofrequency (PRF) is a commonly used, minimally invasive method to treat herpes zoster neuralgia, but the intensity of standard voltage PRF is limited, resulting in patients not getting a lasting therapeutic effect. The therapeutic effect of repeated high-voltage long-duration PRF on acute herpes zoster neuralgia has not been studied. Objective: How to effectively reduce the incidence of postherpetic neuralgia is a serious challenge for clinicians. The purpose of this study was to investigate the clinical efficacy of repeated high-voltage long-duration pulsed radiofrequency therapy for patients with acute herpetic neuralgia and its preventive effect on postherpetic neuralgia. Study design: This is a retrospective study. Setting: The study was carried out in the Pain Department of the affiliated Hospital of Jiaxing College in Jiaxing, China. Methods: Eighty-one patients with acute herpetic neuralgia, who underwent minimally invasive treatment in the Pain Department of Jiaxing First Hospital from January 2020 through December 2020 were retrospectively analyzed. Patients were divided into 3 groups (n = 27 each group) according to treatment method: standard voltage PRF (group S); high-voltage long-duration PRF (group H), and repeated high-voltage long-duration PRF (group R). Pain was assessed according to Numeric Rating Scale (NRS-11) scores and analgesic drug doses were recorded. Blood galectin-3 (gal-3) and interleukin (IL)-6 levels among the 3 groups were compared before treatment and at one, 2, and 4 weeks posttreatment. The incidence of postherpetic neuralgia (PHN) and complications in the 3 groups were recorded. Results: Pain intensity, blood levels of gal-3 and IL-6, and the dose of orally administered gabapentin capsules and morphine were reduced in all patients after treatment. Compared to group S, patients in group R exhibited lower NRS-11 scores, blood levels of gal-3 and IL-6, and dosages of oral gabapentin capsules after treatment. The incidence of PHN was significantly lower at weeks 4, 8, and 12. No adverse reactions occurred in the 3 groups posttreatment. Limitations: Our small sample size is a limitation; we look forward to increasing the sample size in follow-up studies and exploring relevant conclusions in randomized controlled trials. Conclusion: Repeated high-voltage long-duration PRF therapy was an effective treatment for acute herpetic neuralgia and may prevent the occurrence of PHN.
Bounded Variable Logics and Counting: A Study in Finite Models

M. Otto

DOI: https://doi.org/10.1017/9781316716878

1997-03-11

Abstract:O. Introduction.- 1. Definitions and Preliminaries.- 2. The Games and Their Analysis.- 3. The Invariants.- 4. Fixed-Point Logic with Counting.- 5. Related Lindstrom Extensions.- 6. Canonization Problems.- 7. Canonization for Two Variables.
Outcomes of Twice Repeated High-Voltage Long-Duration Pulsed Radiofrequency Treatment in Subacute Postherpetic Neuralgia: a Retrospective Single-Center Analysis

DOI: https://doi.org/10.2147/jpr.s465251

IF: 2.8319

2024-06-12

Journal of Pain Research

Abstract:Huaichang Wen, 1, 2, &ast Yi Wang, 2, &ast Hao Cheng, 2 Bin Wang, 2 Xianwen Hu 1 1 Department of Anesthesiology, The Second Hospital of Anhui Medical University, Hefei, People's Republic of China; 2 Department of Anesthesiology, First Affiliated Hospital of Wannan Medical College, Wuhu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xianwen Hu, Department of Anesthesiology, The Second Hospital of Anhui Medical University, Hefei, 230032, People's Republic of China, Email Background: The treatment of herpes zoster-related pain is challenging, and requires a variety of methods including pulse radio frequency modulation. Among them, single-time high-voltage long-term pulsed radiofrequency (HL-PRF) has been proved to be an effective treatment for subacute postherpetic neuralgia. However, it has the possibility of poor long-term curative effect and recurrence of neuralgia. In this study, we aim to identify the clinical efficacy and safety of twice repeated HL-PRF treatment in patients with subacute postherpetic neuralgia. Design: We conducted a retrospective analysis of subacute postherpetic neuralgia patients who underwent HL-PRF treatment. Setting: Pain Management Department of First Affiliated Hospital of Wannan Medical College. Patients: We enrolled all patients with subacute postherpetic neuralgia, who underwent HL-PRF treatment from January 2023 to October 2023. Measurements: The primary outcome variable was the visual Analog Scale (VAS) scores at 1, 4, 8, and 12 weeks after treatment. Secondary outcomes included Pittsburgh sleep quality index (PSQI), 36-item short-form health survey (SF-36) score, and total effective rate after treatment. Results: A total of 63 patients were included in the analysis. Among them, 33 patients received single-time HL-PRF treatment (Group S) and 30 patients received twice repeated HL-PRF treatment (Group T). Pain scores, PSQI scores, and SF-36 score were reduced in both groups after treatment ( P < 0.001). Compared to group S, the VAS scores, PSQI scores, anxiety scores, and depression scores were significantly lower at 1, 4, 8, and 12 weeks in group T. ( P < 0.001). The total efficiency rate at 12 weeks after treatment of group T was statistically higher than that of group S (60.6% vs 86.7%, P < 0.05). Conclusion: Twice repeated high-voltage long-duration PRF therapy demonstrates satisfactory efficacy in patients with subacute postherpetic neuralgia and is associated with no significant adverse reactions. Keywords: herpes zoster, subacute postherpetic neuralgia, CT-guided, pulsed radiofrequency therapy, dorsal root ganglion Zoster-associated pain (ZAP) refers to the neuropathic pain persisting in patients with herpes zoster (HZ) before, during and after the rash heals. 1 Based on the duration of pain, ZAP is categorized into acute herpetic neuralgia (AHN) within the first month of herpes, subacute herpetic neuralgia (SHN) within three months after the acute phase, and postherpetic neuralgia (PHN), characterized by pain lasting for more than three months. 2,3 Current treatments for ZAP involve both drug therapy and minimally invasive interventional therapy. AHN can be effectively alleviated by early antiviral, oral analgesics, and nerve block. 4,5 However, once PHN develops, the available treatment methods are limited, and the effective rate of cure is also significantly reduced. 6 Therefore, the AHN/SHN is the key period of minimally invasive interventional therapy. Minimally invasive interventional therapy includes pulsed radiofrequency (PRF) technology and spinal cord stimulation, aiming to reduce the need for analgesic drugs and control pain effectively. 7 Although the traditional standard PRF (RF parameters: 42°C, 40V, 2Hz, 20ms, 120s) is widely used to treat postherpetic neuralgia, 8 its therapeutic effect is limited due to low action intensity and short field effect time. In comparison, HL-PRF has shown greater efficacy. 9 Yet, the long-term efficacy of single PRF in the treatment of postherpetic neuralgia is suboptimal. Studies suggest that repetitive standard PRF may outperform single standard PRF, demonstrating better early analgesic effects and reducing the incidence of clinically meaningful ZAP within the first month after treatment. 10 Therefore, our retrospective study aims to observe the clinical efficacy and safety of twice repeated HL-PRF treatment in patients with subacute postherpetic neuralgia and compare the outcomes with a single -Abstract Truncated-

clinical neurology
Visualization of Scientific Knowledge Map Analysis of Radiofrequency Treatment of Zoster-Associated Pain

GUI Xiaodie,KAN Houming,HUANG Yanni,SONG Zhanghu,HUANG Yuting,LI Xiaoqiang,CHEN Wei,SHEN Wen,CHEN Liping

DOI: https://doi.org/10.3969/j.issn.1006-9852.2022.11.005

2022-01-01

Abstract:Objective: To analyze the current situation and hot spots of radiofrequency treatment of zoster-associated pain in recent 10 years by using CiteSpace and VOSviewer software. Methods: The literature related to radiofrequency treatment of zoster-associated pain from 2011 to 2021 was retrieved from China National Knowledge Infrastructure（CNKI） and Web of Science（WoS） Core Collection databases. The retrieved documents were exported in refworks or full-text record format. We quantified and visually analyzed enrolled documents in terms of quantities of documents, journals and keywords by CiteSpace and VOSviewer software. Results: A total of 291 qualified documents were included, including 236 from CNKI database and 55 from WoS Core Collection database. Through the analysis of co-occurrence, emergence and cluster of key words, it can be seen that the documents of CNKI database mainly focus on herpes zoster in special parts（such as trigeminal nerve area）,concomitant symptoms of chronic pain（depression and sleep quality）, treatment methods（ultrasound guidance,high-voltage mode）, combination with other drugs（pregabalin, doxorubicin） and inflammatory immune function, The literature of WoS Core Collection database mainly focuses on the comparison of the efficacy of radiofrequency and other neural regulation technologies（such as spinal cord stimulation）. Conclusion: It is found that radiofrequency treatment of zoster-associated pain is still a research hot spot in China.At present, there is a lack of basic research on the mechanism of radiofrequency treatment of zoster-associated pain, and we should pay attention to basic research in the future.
Pulsed Radiofrequency to the Dorsal Root Ganglion in Acute Herpes Zoster and Postherpetic Neuralgia

Koohyun Kim,Daehyun Jo,EungDon Kim

IF: 4.396

Pain Physician

Abstract:Background: Latent varicella zoster virus reactivates mainly in sensory ganglia such as the dorsal root ganglion (DRG) or trigeminal ganglion. The DRG contains many receptor channels and is an important region for pain signal transduction. Sustained abnormal electrical activity to the spinal cord via the DRG in acute herpes zoster can result in neuropathic conditions such as postherpetic neuralgia (PHN). Although the efficacy of pulsed radiofrequency (PRF) application to the DRG in various pain conditions has been previously reported, the application of PRF to the DRG in patients with herpes zoster has not yet been studied. Objectives: The aim of the present study was to compare the clinical effects of PRF to the DRG in patients with herpes zoster to those of PRF to the DRG in patients with PHN. Study design: Retrospective comparative study. Setting: University hospital pain center in Korea. Methods: The medical records of 58 patients who underwent PRF to the DRG due to zoster related pain (herpes zoster or PHN) were retrospectively analyzed. Patients were divided into 2 groups according to the timing of PRF after zoster onset: an early PRF group (within 90 days) and a PHN PRF group (more than 90 days). The efficacy of PRF was assessed by a numeric rating scale (NRS) and by recording patient medication doses before PRF and at one week, 4 weeks, 8 weeks, and 12 weeks after PRF. Results: Pain intensity was decreased after PRF in all participants. However, the degree of pain reduction was significantly higher in the early PRF group. Moreover, more patients discontinued their medication in the early PRF group, and the PRF success rate was also higher in the early PRF group. Limitations: The relatively small sample size from a single center, short duration of review of medical records, and the retrospective nature of the study. Conclusions: PRF to the DRG is a useful treatment for treatment-resistant cases of herpes zoster and PHN. Particularly in herpes zoster patients with intractable pain, application of PRF to the DRG should be considered for pain control and prevention of PHN.Key words: Pulsed radiofrequency, dorsal root ganglion, herpes zoster, postherpetic neuralgia.
Combined Therapy of Paravertebral Nerve Pulsed Radiofrequency and Subcutaneous Block for Acute/subacute Herpetic Neuralgia

Wei Zhang,Bin Yu,Zipu Jia,Chunmei Zhao,Fang Luo

DOI: https://doi.org/10.1097/ajp.0000000000001202

IF: 3.423

2024-02-05

The Clinical Journal of Pain

Abstract:Objectives: This retrospective study aimed to investigate the effectiveness and safety of early combined therapy with CT-guided paravertebral nerve (PVN) pulsed radiofrequency (PRF) and subcutaneous block on acute/subacute herpes zoster (HZ). Methods: A total of 98 medical records were analyzed. All patients underwent CT-guided PRF on PVN immediately followed by a single subcutaneous block with lidocaine and dexamethasone in acute/subacute phase. The therapy efficacy was evaluated by pain numeric rating scale (NRS) and effective rate, which was defined as a percent of cases with a reduction in pain NRS>50%, at day 1, week 2, 4, 12 and 24 after procedure. The incidences of medication reduction and postherpetic neuralgia (PHN) were also retrieved. Further comparison was conducted between acute group (disease duration<30 d from HZ onset) and subacute group (30 d<duration<90 d from HZ onset). Results: Early combined therapy indicated an immediate and sustained improvement in pain NRS as compared to before treatment ( P <0.0001), with the effective rates of 74%, 79%, 80%, 76% and 79% at day 1, week 2, 4, 12 and 24 after procedure, respectively. At the end of follow - up, the proportion of patients with a reduction of>50% in prior medications amounted to 83% and the incidence of clinically meaningful PHN decreased to 23%. The clinical efficacy was more profound in acute group than in subacute group at every time points ( P <0.05). No severe complications occurred. Discussion: Our data revealed surprising levels of pain relief by combination therapies of PRF and subcutaneous block targeting different sites of pain pathway, thus suggesting a valuable treatment option for acute/subacute herpetic neuralgia.

clinical neurology,anesthesiology
Clinical Study of Spinal Cord Stimulation and Pulsed Radiofrequency for Management of Herpes Zoster-Related Pain Persisting Beyond Acute Phase in Elderly Patients

Botao Liu,Yang Yang,Zhongyi Zhang,Haining Wang,Bifa Fan,Lei Sima

IF: 4.396

Pain Physician

Abstract:Background: Postherpetic neuralgia (PHN) occurs in 9% to 34% of herpes zoster (HZ) patients, and the incidence of PHN is positively correlated with age. A number of patients suffer from poor therapeutic effects or intolerable side effects and need to accept minimally invasive analgesia. Objectives: This study aimed to investigate the effects of spinal cord stimulation (SCS) and pulsed radiofrequency (PRF) on the treatment of elderly patients with HZ-related pain persisting beyond the acute phase. Study design: A prospective, randomized-controlled trial. Setting: Research was conducted at the National Pain Management and Research Center, China-Japan Friendship Hospital (Beijing, China). Methods: We selected 63 patients aged over 50 years with zoster-related pain of 1 to 6 months onset. They were randomly divided into an SCS group and a PRF group. In the SCS group, the stimulus electrodes were placed in the affected spinal ganglion segment of the epidural space for 2 weeks. In the PRF group, the radiofrequency needle was percutaneously punctured in the affected dorsal root ganglion. The main outcome measures were the Numeric Rating Scale (NRS-11) score, response rate, and complete remission rate. The secondary endpoint was defined as the use of analgesics and calcium channel antagonists. Results: The NRS-11 score in the SCS group decreased to 2.90 ± 1.83 (1 week post operation) and 4.37 ± 2.43 (24 weeks post operation), while that in the PRF group decreased to 3.13 ± 1.78 and 4.23 ± 2.64, respectively (compared with baseline, P < .001); there was no significant difference between the 2 groups (P > .05) . The effective rate of pain management was in the range of 56.67% to 81.25%, and the complete pain relief rate ranged from 37% to 71%. The number of patients still using analgesics and calcium channel antagonists after operation were significantly less than those pre-operation (P < .001). Univariate and multivariate logistic regression analyses showed that the operation method, age, gender, and course of disease did not affect surgical efficacy. Limitations: The main limitation of this study is that all the cases were from the same center. Conclusion: It therefore can be concluded that SCS and PRF can effectively relieve PHN. Key words: Spinal cord stimulation, pulsed radiofrequency, postherpetic neuralgia.
Which Minimally Invasive Therapy Is Most Effective For The Treatment Of Postherpetic Neuralgia? An Updated Network Meta-Analysis

Bei Wen,Yuguang Huang,Li Xu

DOI: https://doi.org/10.1016/j.jpain.2023.02.146

2023-04-01

Abstract:Postherpetic neuralgia (PHN) is the most common and annoying complication of herpes zoster, which significantly reduces patients' quality of life. Minimally invasive therapies are commonly needed because drug therapy alone is not always effective, particularly for the elderly and patients with long-term pain. To figure out which interventional therapy is most effective, we first performed a paired meta-analysis, followed by a Bayesian network meta-analysis with direct or indirect comparisons for nine different therapies. After searching, 283 studies were found, and 14 were included for analysis. We found that short-term spinal cord stimulation (SCS) is the most effective individual therapy a month, three months, six months, and a year after the treatment, followed by pulsed radiofrequency (PRF), BTX-A therapy, nerve block (NB), and subcutaneously injection (SC). The addition of dexamethasone injection could prompt the efficacy of PRF better than SCS. After the treatment of a month, PRF+NB was more effective than SCS, but SCS surpassed the former after three and six months. Interestingly, SC alone could not alleviate the pain after the treatment of 2 weeks and a month, but after three months, the pain was mitigated. In conclusion, for patients suffering from PHN, using minimally invasive therapies such as SCS and PRF based on regular administration of anti-neuropathic pain drugs seems to be a better choice. The combination of PRF with dexamethasone or local anesthetics can achieve a better curative effect.Funding: NSFC (82271262; 82071252); the Fundamental Research Funds for the Central Universities (3332020120) NSFC (82271262; 82071252); the Fundamental Research Funds for the Central Universities (3332020120).

neurosciences,clinical neurology
[Cryptosporidiosis--strongly underdiagnosed diarrheal disease. Specimen taking should be increased in unclear diagnoses].

B. Svenungsson,M. Insulander,B. de Jong,M. Lebbad

2009-07-08

Abstract:
Enhancing Predictive Accuracy for Acute Herpetic Neuralgia Treatment: A Fresh Perspective on Pulsed Radiofrequency Therapy Research

Chaocan Hong,Yijie Ma,Changhu Yan

DOI: https://doi.org/10.2147/jpr.s500107

IF: 2.8319

2024-11-27

Journal of Pain Research

Abstract:Chaocan Hong, Yijie Ma, Changhu Yan Jinjiang Hospital of Traditional Chinese Medicine, Jinjiang City, Fujian Province, 362200, People's Republic of China Correspondence: Changhu Yan, Jinjiang Hospital of Traditional Chinese Medicine, No. 1105 Quan'an Middle Road, Jinjiang City, Fujian Province, 362200, People's Republic of China, Email View the original paper by Mr Zhao and colleagues We have taken a keen interest in the study recently published in your journal, titled "Predictive Value of Current Perception Threshold for Prognosis of Pulsed Radiofrequency in Patients with Acute Herpetic Neuralgia". 1 While the study offers valuable contributions to the field, there are a few areas where additional considerations could enhance the robustness and applicability of the findings. Firstly, although the study considered the distribution of herpes on both sides of the body, it did not extensively explore the specific characteristics of herpes zoster, such as the location of the lesions and the nature of the associated pain. 2 The presentation of herpes zoster neuralgia varies with the affected nerve ganglia, making detailed information on lesion sites critical for predicting treatment responses and outcomes. For instance, areas like the face and head are notably sensitive due to higher nerve densities, potentially resulting in intensified pain. 3 Failure to thoroughly analyze lesion locations might overlook variations in treatment efficacy, consequently impacting the precision of Current Perception Threshold (CPT) evaluations and the customization of treatment plans. Secondly, the article fails to address whether an analysis of collinearity among the variables, such as the calculation of the Variance Inflation Factor (VIF), was performed. As Table 4 illustrates, Zhao et al directly apply results from univariate logistic regression—including age, preoperative NRS scores, and CPT ratios at 5Hz and 2000Hz—to their multivariate logistic regression analysis without assessing collinearity among the variables. In terms of varying CPT ratios, post-herpetic neuralgia (PHN) may simultaneously impact multiple types of nerve fibers in specific pathological states, potentially exhibiting correlations even among CPT measurements targeting different fibers. 4 A check for collinearity could significantly enhance the robustness and reliability of the model's outcomes. To enhance patient care, a multidisciplinary approach to managing Acute Herpetic Neuralgia (AHN) should be adopted in the future. This can be achieved by establishing a collaborative treatment team that includes pain management specialists, neurologists, dermatologists, and mental health professionals, offering more comprehensive and effective management strategies. Such a team-based approach leverages the expertise of diverse professionals to tackle the complex and multifaceted challenges associated with herpes zoster neuralgia, thereby improving patient outcomes through an integrated treatment plan. In conclusion, the insights into current perception thresholds in pulsed radiofrequency treatment presented by this study are invaluable. Nevertheless, realizing the full potential of such research requires more extensive collaboration. It is hoped that future studies will incorporate a broader range of perspectives, including those from traditional Chinese medicine and artificial intelligence technology, to deepen our understanding of acute herpetic neuralgia and refine treatment approaches. There is no funding to report. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this communication. 1. Zhao C, Lu Z, Hua B, et al. Predictive value of current perception threshold for prognosis of pulsed radiofrequency in patients with acute herpetic neuralgia. J Pain Res . 2024;17:3241–3253. doi:10.2147/JPR.S472535 2. Lin Z, Yu LY, Pan SY, Cao Y, Lin P. Development of a prediction model and corresponding scoring table for postherpetic neuralgia using six machine learning algorithms: a retrospective study. Pain Ther . 2024;13(4):883–907. doi:10.1007/s40122-024-00612-7 3. Antony AB, Mazzola AJ, Dhaliwal GS, Hunter CW. Neurostimulation for the treatment of chronic head and facial pain: a literature review. Pain Physician . 2019;22(5):447–477. doi:10.36076/ppj/2019.22.447 4. Buonocore M, Gatti AM, Amato G, Aloisi AM, Bonezzi C. Allodynic skin in post-herpetic neuralgia: histological correlates. J Cell Physiol . 2012;227(3):934–938. doi:10.1002/jcp.22804

clinical neurology
Pulsed radiofrequency of dorsal root ganglion of upper thoracic segment for herpes zoster neuralgia: Case report

Yong Fei,Jiajia Deng,Hui Lv,Ming Yao,Tingting Wang,Bing Huang

DOI: https://doi.org/10.1097/MD.0000000000020807

2020-06-19

Abstract:Rationale: Pulsed radiofrequency (PRF) therapy of dorsal root ganglion is effective in treating acute stage shingles neuralgia of chest and back. Herein, a case of herpetic neuralgia with difficult puncture of dorsal root ganglion of upper thoracic segment is report. Patient concerns: A 62-year-old male patient was admitted to the hospital for 2 days for herpes zoster with paroxysmal needle-like pain in the left chest and back. The skin lesion area of herpes zoster and the superficial location of neuralgia was left T2-4, and visual analog scale (VAS) score was 6 points. Diagnosis: Two days ago, the patient had paroxysmal needle-like pain in the left chest and back, without herpes, and was admitted to the hospital for emergency treatment. Chest pain and myocardial infarction were considered; however, troponin, myocardial enzyme spectrum, and blood amylase were in the normal range. On the evening of the same day, the patient presented green bean-sized blisters distributed in clusters along the left T2-4 nerve as a banded pattern. Thus, the patient was diagnosed as shingles. Intervention: Oral gabapentin capsules, varaciclovir tablets, mecobalamine tablets, and amitriptyline hydrochloride tablets were administered, and topical aciclovir cream was applied. The VAS score after the above treatment was 5 points. The patient underwent computed tomography-guided PRF surgery on the dorsal root ganglion. Outcome: Postoperative pain was relieved. One month post-surgery, no oral analgesic drugs were administered. The VAS score was 1 point, and the pain completely disappeared at 3 months post-surgery. Conclusions: Herpes zoster is most common in the chest and back. The PRF of dorsal root ganglion cannot access the target by conventional puncture, and can be completed by thoracic sympathetic nerve radiofrequency puncture path.
[Catheter complications during parenteral nutrition].

M. Taniguchi,H. Takeyama,T. Manabe

2001-05-01

Abstract:
Interventions for zoster-associated pain: A retrospective study based on the clinical database

Lu Chen,Jun Li,Hui Liu,Pingliang Yang,Yunxia Zuo,Ling Ye

DOI: https://doi.org/10.3389/fneur.2022.1056171

IF: 3.4

2022-11-25

Frontiers in Neurology

Abstract:Background: Herpes zoster (HZ)-associated pain can lead to severe pain and reduced quality of life. Exploring effective treatment and the risk factors of zoster-associated pain has become important. Methods: Interventions including nerve block, radiofrequency, and thermocoagulation were used for zoster-associated pain. The data of 131 patients with HZ and 230 patients with postherpetic neuralgia (PHN) were collected at baseline, 2 weeks, 3, 6, and 12 months after the intervention. Visual analog scale (VAS) and Brief Pain Inventory (BPI) scores at different time points were analyzed by two-way repeated measures ANOVA with Group as the between-subject variable (different pain durations and areas), Time as the within-subject variable (baseline, 2 weeks, 3 months, 6 months, and 12 months), and Group × Time as the two-way interaction. Besides, the effective rate, adverse effects, and medication were also recorded. The risk factors of PHN were analyzed by logistic regression. Results: A total of 25 (19.08%) patients with HZ continued to have pain in the initially affected area after 3 months. The VAS scores and the BPI quality of life scores of patients with HZ-associated pain were significantly reduced from baseline to 2 weeks, 3, 6, and 12 months after the interventions. There was no significant difference in VAS and BPI scores in different pain areas and pain durations. No significant Group × Time interaction was observed. Age, diabetes mellitus, and immune-related diseases were risk factors of PHN. Conclusion: Interventions could significantly improve the pain degree and life quality of patients with zoster-associated pain, and the positive effect of intervention did not change with pain duration and area. Advanced age, diabetes, and immune-related diseases are risk factors of PHN.

neurosciences,clinical neurology

Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.

Comparing the Efficacy and Safety of High-Voltage and Standard-Voltage Pulsed Radiofrequency for the Treatment of Postherpetic Neuralgia: a Pooled Analysis from Randomized Controlled Trials

Effect of CT-Guided Repeated Pulsed Radiofrequency on Controlling Acute/Subacute Zoster-Associated Pain: A Retrospective Cohort Study

Development of a Model for Predicting the Effectiveness of Pulsed Radiofrequency on Zoster-Associated Pain

Clinical efficacy of high-voltage pulsed radiofrequency combined with stellate ganglion block in the acute phase of thoracic and dorsal herpes zoster neuralgia under dual guidance of ultrasound and C-arm

Effective treatment of high-voltage pulsed radiofrequency combined with oxygen-ozone injection in acute zoster neuralgia

Gonadotropin-releasing hormone and prostaglandin F2 alpha for postpartum dairy cows: estrous, ovulation, and fertility traits.

A central and peripheral dual neuromodulation strategy in pain management of zoster-associated pain

Effect of Repeated High-voltage Long-duration Pulsed Radiofrequency on Herpetic Neuralgia

Bounded Variable Logics and Counting: A Study in Finite Models

Outcomes of Twice Repeated High-Voltage Long-Duration Pulsed Radiofrequency Treatment in Subacute Postherpetic Neuralgia: a Retrospective Single-Center Analysis

Visualization of Scientific Knowledge Map Analysis of Radiofrequency Treatment of Zoster-Associated Pain

Pulsed Radiofrequency to the Dorsal Root Ganglion in Acute Herpes Zoster and Postherpetic Neuralgia

Combined Therapy of Paravertebral Nerve Pulsed Radiofrequency and Subcutaneous Block for Acute/subacute Herpetic Neuralgia

Clinical Study of Spinal Cord Stimulation and Pulsed Radiofrequency for Management of Herpes Zoster-Related Pain Persisting Beyond Acute Phase in Elderly Patients

Which Minimally Invasive Therapy Is Most Effective For The Treatment Of Postherpetic Neuralgia? An Updated Network Meta-Analysis

[Cryptosporidiosis--strongly underdiagnosed diarrheal disease. Specimen taking should be increased in unclear diagnoses].

Enhancing Predictive Accuracy for Acute Herpetic Neuralgia Treatment: A Fresh Perspective on Pulsed Radiofrequency Therapy Research

Pulsed radiofrequency of dorsal root ganglion of upper thoracic segment for herpes zoster neuralgia: Case report

[Catheter complications during parenteral nutrition].

Interventions for zoster-associated pain: A retrospective study based on the clinical database